MAPT and Mental deterioration: In participants who were in the Alzheimer’s continuum, as described by Jack et al in the NIA-AA research framework [32] (i.e., those with at least abnormal CSF Aβ results), weight loss was associated with higher levels of CSF tau-related, axonal damage and synaptic dysfunction biomarkers, as well as faster cognitive decline.